Within the EU’s 7th Framework programme, a grant of EUR 6 million has been awarded to the UNISEC Consortium, a joint effort to develop a new universal influenza vaccine involving three university partners, five national health institutes and four small and medium-sized enterprises. In this context, UNISEC partners Prof. E. Hak (Pharmacoepidemiology and Pharmacoeconomics) and Prof. E. Frijlink (Pharmaceutical Technology and Biopharmacy) of the
Groningen Research Institute of Pharmacy
will receive EUR 1.5 million; Prof. A. Huckriede (Molecular Virology) of the UMCG will receive EUR 0.5 million.
Combining leading expertise in influenza vaccine research and development with a proven track record, including participation in the successful EU FLUSECURE project, the UNISEC partners aim to develop a vaccine that offers both universal protection and commercial opportunity. In a single study, the three most promising vaccines are identified, further developed and clinically tested. The results will directly contribute to the development of a timely, longer-term, broader, more effective and cheaper universal vaccine for the prevention of annual and pandemic influenza.
The size and shape of dunes varies greatly around the world: in Europe they're tall and narrow, while in the US they're low and wide. A new study has found that this is partly because dunes are constructed by plants with different ‘movement strategies’...
More than 200 researchers and their teams can begin to work on social and scientific issues in close collaboration with public and private parties. This close collaboration will take place in 17 research projects.
Bij Koninklijk Besluit heeft de honderd jaar oude vakvereniging van Nederlandse en Vlaamse sterrenkundigen het predicaat ‘Koninklijk’ gekregen. Sinds maandag 27 mei gaat de vereniging door het leven als de Koninklijke Nederlandse Astronomenclub (KNA...